Evaluation of Tuberculosis Preventive Treatment Uptake Among People Living with HIV in PEPFAR-Supported Facilities in Zimbabwe

Tuberculosis preventive treatment (TPT) reduces the incidence of tuberculosis (TB) among people living with HIV (PLHIV), but its coverage remains suboptimal in most settings. We conducted a cross-sectional study to describe TPT uptake among PLHIV and factors influencing TPT initiation. Healthcare wo...

Full description

Saved in:
Bibliographic Details
Published in:Tropical medicine and infectious disease Vol. 10; no. 10; p. 296
Main Authors: Timire, Collins, Mapuranga, Tawanda, Ncube, Ronald T., Maphosa, Talent, Dube, Sithabiso, Mlilo, Nqobile, Chiteve, Cynthia, Dar Berger, Selma, Mugurungi, Owen, Kavenga, Fungai, Mutasa-Apollo, Tsitsi, Ncube, Manners, Gwanzura, Clorata, Charles, Macarthur, Dlodlo, Riitta A., Ershova, Julia
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 18.10.2025
Subjects:
Adults
Analysis
childhood tuberculosis
collaborative TB-HIV services
Contraindications
Diagnosis
Disease prevention
Drug therapy
Enrollments
Health facilities
HIV
HIV (Viruses)
HIV patients
Human immunodeficiency virus
Infections
isoniazid preventive therapy
Medical laboratories
Medical personnel
Medicine, Preventive
Preventive health services
Rifapentine
sub-Saharan Africa
TB infection
Tuberculosis
Zimbabwe
United States
Switzerland
India
United States > US
isoniazid preventive therapy
sub-Saharan Africa
childhood tuberculosis
TB infection
collaborative TB-HIV services
ISSN:2414-6366, 2414-6366
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tuberculosis preventive treatment (TPT) reduces the incidence of tuberculosis (TB) among people living with HIV (PLHIV), but its coverage remains suboptimal in most settings. We conducted a cross-sectional study to describe TPT uptake among PLHIV and factors influencing TPT initiation. Healthcare workers (HCWs) in selected facilities were trained and supported to strengthen TPT management among PLHIV, including children living with HIV (CLHIV). Of 1309 enrolled PLHIV, 1268 (97%) were eligible for TPT; 1078 (85%) initiated TPT, including 663/776 (86%) among those currently on ART and 415/492 (84%) among clients newly on ART. The major reasons for not starting TPT included stock-outs of TPT medicines, TB disease, and refusal of TPT, mostly by CLHIV and adults currently on ART. Optimal and sustained uptake of TPT can be achieved through ensuring uninterrupted stocks of TPT medicines, including shorter regimens and pediatric formulations, addressing knowledge deficits among HCWs, and improving demand for TPT by educating PLHIV and caregivers of CLHIV about the benefits and risks of TPT formulations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2414-6366
2414-6366
DOI:10.3390/tropicalmed10100296